Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

First robotic nipple-sparing mastectomy performed in New York City

17

Nov 2026

First robotic nipple-sparing mastectomy performed in New York City

Mount Sinai Tisch Cancer Center has performed the first robotic nipple-sparing mastectomy in New York City. The procedure, which used Intuitive Surgical's da Vinci Single-Port (SP) robotic system following U.S. Food and Drug Administration (FDA) clearance earlier this year, marks a milestone in breast surgery and introduces an emerging minimally invasive capability at Mount Sinai.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.